ISRCTN24452099
Recruiting
Not Applicable
Perspective study on an effective treatment for acute myeloid leukemia with decitabine and chemotherapy
Heilongjiang Institute for Hematology and Oncology Research (China)0 sites3,000 target enrollmentOctober 23, 2014
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Acute myeloid leukemia (AML)
- Sponsor
- Heilongjiang Institute for Hematology and Oncology Research (China)
- Enrollment
- 3000
- Status
- Recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Any age AML patients (except APL) at different treatment stages, who are responsive or non\-responsive to conventional treatments are all included in this trial
- •2\. Patients agreed to receive the treatment
Exclusion Criteria
- •1\. Previous history of severe cardiovascular disease (coronary arterial disease, stroke, etc.)
- •2\. Severe chronic disease with poor prognosis (liver disease, kidney disease, etc.)
- •3\. Illegal drug use or chronic alcoholism
- •4\. Physical limitations, mental or intellectual disabilities
- •5\. Any condition that may affect the development of this trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical outcomes of conservative treatment for acute anterior talofibular ligament avulsion fracture and Predisposing factors of chronic ankle instability ; Prospective cohort studyKCT0007020Wonkwang University Hospital80
Not yet recruiting
Phase 1
Clinical efficacy and mechanism observation of acupuncture in improving skeletal muscle consumption in advanced lung cancer cachexiaCancer CachexiaITMCTR1900002392Chongqing Jiulongpo District Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
Therapeutic effect of acupuncture and moxa combustion on prostate hyperplasiaITMCTR2000003082Shanghai 4th People's Hospital affiliated to Tongji University
Not yet recruiting
Not Applicable
Test of a strategy for childhood obesity based on the Food Guide for the Brazilian PopulatioRBR-3st5snHospital Universitário Pedro Ernesto
Recruiting
Not Applicable
To evaluate hydroxyurea and imatinib treatment for chronic myeloid leukemiaISRCTN54990932Heilongjiang Institute for Hematology and Oncology Research2,000